Farnesyltransferase--new insights into the zinc-coordination sphere paradigm: evidence for a carboxylate-shift mechanism.

Despite the enormous interest that has been devoted to the study of farnesyltransferase, many questions concerning its catalytic mechanism remain unanswered. In particular, several doubts exist on the structure of the active-site zinc coordination sphere, more precisely on the nature of the fourth ligand, which is displaced during the catalytic reaction by a peptide thiolate. From available crystallographic structures, and mainly from x-ray absorption fine structure data, two possible alternatives emerge: a tightly zinc-bound water molecule or an almost symmetrical bidentate aspartate residue (Asp-297beta). In this study, high-level theoretical calculations, with different-sized active site models, were used to elucidate this aspect. Our results demonstrate that both coordination alternatives lie in a notably close energetic proximity, even though the bidentate hypothesis has a somewhat lower energy. The Gibbs reaction and activation energies for the mono-bidentate conversion, as well as the structure for the corresponding transition state, were also determined. Globally, these results indicate that at room temperature the mono-bidentate conversion is reversible and very fast, and that probably both states exist in equilibrium, which suggests that a carboxylate-shift mechanism may have a key role in the farnesylation process by assisting the coordination/displacement of ligands to the zinc ion, thereby controlling the enzyme activity. Based on this equilibrium hypothesis, an explanation for the existing contradictions between the crystallographic and x-ray absorption fine structure results is proposed.

[1]  J. Stewart Optimization of parameters for semiempirical methods II. Applications , 1989 .

[2]  C. Fierke,et al.  Function and mechanism of zinc metalloenzymes. , 2000, The Journal of nutrition.

[3]  Pedro Alexandrino Fernandes,et al.  Theoretical studies on the mechanism of inhibition of Ribonucleotide Reductase by (E)-2'-Fluoromethylene-2'-deoxycitidine-5'-diphosphate. , 2003, Journal of the American Chemical Society.

[4]  Leif A. Eriksson,et al.  The reduction of ribonucleotides catalyzed by the enzyme ribonucleotide reductase , 2002 .

[5]  S. Moores,et al.  Sequence dependence of protein isoprenylation. , 1991, The Journal of biological chemistry.

[6]  Mayuso Kuno,et al.  Theoretical investigation on nevirapine and HIV-1 reverse transcriptase binding site interaction, based on ONIOM method , 2003 .

[7]  P. Casey,et al.  H-Ras peptide and protein substrates bind protein farnesyltransferase as an ionized thiolate. , 1998, Biochemistry.

[8]  T. Ziegler Approximate Density Functional Theory as a Practical Tool in Molecular Energetics and Dynamics , 1991 .

[9]  Pedro Alexandrino Fernandes,et al.  Theoretical studies on the mode of inhibition of ribonucleotide reductase by 2'-substituted substrate analogues. , 2003, Chemistry.

[10]  P. Casey,et al.  Crystal Structure of Protein Farnesyltransferase at 2.25 Angstrom Resolution , 1997, Science.

[11]  S. Sebti,et al.  Inhibitors of protein farnesyltransferase as novel anticancer agents. , 2002, Current Topics in Medicinal Chemistry.

[12]  Thom Vreven,et al.  Model studies of the structures, reacitivities, and reaction mechanisms of metalloenzymes , 2001, IBM J. Res. Dev..

[13]  C. Bauschlicher,et al.  A comparison of density functional theory withab initio approaches for systems involving first transition row metals , 1995 .

[14]  Y. Reiss,et al.  Divalent cation and prenyl pyrophosphate specificities of the protein farnesyltransferase from rat brain, a zinc metalloenzyme. , 1992, The Journal of biological chemistry.

[15]  C. Poulter,et al.  Yeast protein farnesyltransferase. Site-directed mutagenesis of conserved residues in the beta-subunit. , 1997, Biochemistry.

[16]  M. Brown,et al.  Resistance of K-RasBV12 proteins to farnesyltransferase inhibitors in Rat1 cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[17]  K. Morokuma,et al.  Effects of the protein environment on the structure and energetics of active sites of metalloenzymes. ONIOM study of methane monooxygenase and ribonucleotide reductase. , 2002, Journal of the American Chemical Society.

[18]  U. Ryde,et al.  Carboxylate binding modes in zinc proteins: a theoretical study. , 1999, Biophysical journal.

[19]  K. Morokuma,et al.  On the application of the IMOMO (integrated molecular orbital + molecular orbital) method , 2000 .

[20]  J. Stewart Optimization of parameters for semiempirical methods. III Extension of PM3 to Be, Mg, Zn, Ga, Ge, As, Se, Cd, In, Sn, Sb, Te, Hg, Tl, Pb, and Bi , 1991 .

[21]  P. Casey,et al.  Inhibition of purified p21 ras farnesyl:protein transferase by Cys-AAX tetrapeptides , 1990, Cell.

[22]  Wolfram Koch,et al.  The performance of density functional/Hartree-Fock hybrid methods: the bonding in cationic first-row transition metal methylene complexes , 1995 .

[23]  Giovanni Scalmani,et al.  New developments in the polarizable continuum model for quantum mechanical and classical calculations on molecules in solution , 2002 .

[24]  Pedro Alexandrino Fernandes,et al.  Theoretical study of ribonucleotide reductase mechanism‐based inhibition by 2′‐azido‐2′‐deoxyribonucleoside 5′‐diphosphates , 2004, J. Comput. Chem..

[25]  P. Fernandes,et al.  Theoretical insights into the mechanism for thiol/disulfide exchange. , 2004, Chemistry.

[26]  C. Der,et al.  Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Margareta R. A. Blomberg,et al.  Modeling Electron Transfer in Biochemistry: A Quantum Chemical Study of Charge Separation in Rhodobacter sphaeroides and Photosystem II , 1998 .

[28]  K Nadassy,et al.  Analysis of zinc binding sites in protein crystal structures , 1998, Protein science : a publication of the Protein Society.

[29]  S. Ayral-Kaloustian,et al.  Protein farnesyltransferase inhibitors. , 2002, Current medicinal chemistry.

[30]  H. Hellinga,et al.  The crystal structure of human protein farnesyltransferase reveals the basis for inhibition by CaaX tetrapeptides and their mimetics , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  C. Der,et al.  Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[32]  P. Casey,et al.  Evidence for a Catalytic Role of Zinc in Protein Farnesyltransferase , 1997, The Journal of Biological Chemistry.

[33]  Chia‐Yu Huang,et al.  Farnesyltransferase inhibitors: recent advances , 2004 .

[34]  A. Becke Density-functional thermochemistry. III. The role of exact exchange , 1993 .

[35]  G. Klebe,et al.  Farnesyltransferase inhibitors inhibit the growth of malaria parasites in vitro and in vivo. , 2004, Angewandte Chemie.

[36]  Giovanni Scalmani,et al.  Energies, structures, and electronic properties of molecules in solution with the C‐PCM solvation model , 2003, J. Comput. Chem..

[37]  J. Tomasi,et al.  Ab initio study of ionic solutions by a polarizable continuum dielectric model , 1998 .

[38]  Leif A. Eriksson,et al.  Hydrogen Atom Transfer in Ribonucleotide Reductase (RNR) , 1998 .

[39]  Jacopo Tomasi,et al.  A new integral equation formalism for the polarizable continuum model: Theoretical background and applications to isotropic and anisotropic dielectrics , 1997 .

[40]  M. Bräuer,et al.  Evaluation of the accuracy of PM3, AM1 and MNDO/d as applied to zinc compounds , 2000 .

[41]  Wely B. Floriano,et al.  Theoretical study of arginine-carboxylate interactions , 1999 .

[42]  Per E M Siegbahn,et al.  Catalytic mechanism of matrix metalloproteinases: two-layered ONIOM study. , 2002, Inorganic chemistry.

[43]  L. Gierasch,et al.  Sequence requirement for peptide recognition by rat brain p21ras protein farnesyltransferase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[44]  R. Diehl,et al.  Mutational Analysis of Conserved Residues of the β-Subunit of Human Farnesyl:Protein Transferase* , 1997, The Journal of Biological Chemistry.

[45]  P. Casey,et al.  The basis for K-Ras4B binding specificity to protein farnesyltransferase revealed by 2 A resolution ternary complex structures. , 2000, Structure.

[46]  H. Stoll,et al.  Energy-adjustedab initio pseudopotentials for the second and third row transition elements , 1990 .

[47]  Stephen B. Long,et al.  Reaction path of protein farnesyltransferase at atomic resolution , 2002, Nature.

[48]  C. Marshall,et al.  All ras proteins are polyisoprenylated but only some are palmitoylated , 1989, Cell.

[49]  Zhanghua Wu,et al.  Crystal structure of farnesyl protein transferase complexed with a CaaX peptide and farnesyl diphosphate analogue. , 1998, Biochemistry.

[50]  S. Croft,et al.  Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agents. , 2004, Journal of medicinal chemistry.

[51]  P. Casey,et al.  Kinetic studies of protein farnesyltransferase mutants establish active substrate conformation. , 2003, Biochemistry.

[52]  J. Stewart Optimization of parameters for semiempirical methods I. Method , 1989 .

[53]  C. Fierke,et al.  Mutagenesis Studies of Protein Farnesyltransferase Implicate Aspartate β352 as a Magnesium Ligand* , 2003, Journal of Biological Chemistry.

[54]  C. Fierke,et al.  Structural characterization of the zinc site in protein farnesyltransferase. , 2003, Journal of the American Chemical Society.

[55]  Jacopo Tomasi,et al.  Continuum solvation models: A new approach to the problem of solute’s charge distribution and cavity boundaries , 1997 .

[56]  K. Morokuma,et al.  A NEW ONIOM IMPLEMENTATION IN GAUSSIAN98. PART I. THE CALCULATION OF ENERGIES, GRADIENTS, VIBRATIONAL FREQUENCIES AND ELECTRIC FIELD DERIVATIVES , 1999 .

[57]  P. Casey,et al.  Substrate Binding Is Required for Release of Product from Mammalian Protein Farnesyltransferase* , 1997, The Journal of Biological Chemistry.

[58]  S. Johnston,et al.  Farnesyl transferase inhibitors: a novel targeted tnerapy for cancer. , 2001, The Lancet. Oncology.

[59]  Charles W. Bauschlicher,et al.  A comparison of the accuracy of different functionals , 1995 .

[60]  Per E. M. Siegbahn,et al.  Theoretical Study of the Substrate Mechanism of Ribonucleotide Reductase , 1998 .

[61]  William N. Lipscomb,et al.  Recent Advances in Zinc Enzymology. , 1996, Chemical reviews.

[62]  P. Casey,et al.  Cocrystal structure of protein farnesyltransferase complexed with a farnesyl diphosphate substrate. , 1998, Biochemistry.

[63]  Parr,et al.  Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. , 1988, Physical review. B, Condensed matter.

[64]  P. Chakrabarti,et al.  Interaction of metal ions with carboxylic and carboxamide groups in protein structures. , 1990, Protein engineering.

[65]  A. Becke Density-functional thermochemistry. , 1996 .

[66]  K. Kaibuchi,et al.  Small GTP-binding proteins. , 1992, International review of cytology.

[67]  Crowther,et al.  Protein farnesyltransferase: structure and implications for substrate binding , 1998, Biochemistry.

[68]  B. Vallee,et al.  Active-site zinc ligands and activated H2O of zinc enzymes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[69]  M. Harding,et al.  Geometry of metal-ligand interactions in proteins. , 2001, Acta crystallographica. Section D, Biological crystallography.

[70]  Ping Liu,et al.  In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus. , 2003, The Journal of clinical investigation.

[71]  D. Chakrabarti,et al.  Protein Farnesyltransferase and Protein Prenylation inPlasmodium falciparum * , 2002, The Journal of Biological Chemistry.

[72]  F. Tamanoi,et al.  Mutants of Saccharomyces cerevisiae defective in the farnesylation of Ras proteins. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[73]  Michael Dolg,et al.  Energy‐adjusted ab initio pseudopotentials for the first row transition elements , 1987 .

[74]  P. Casey,et al.  Kinetic analysis of zinc ligand mutants of mammalian protein farnesyltransferase. , 1998, Biochemistry.

[75]  C. Poulter,et al.  A mechanism for posttranslational modifications of proteins by yeast protein farnesyltransferase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.